ECM Therapeutics, Inc.

Develops extracellular matrix–based regenerative materials for challenging wounds (diabetic foot ulcers, venous leg ulcers, pressure injuries, and complex tunneling/draining wounds). Lead wound-care product conforms to wound geometry and remains in place in wet environments; pipeline includes ECM therapies for ocular surface repair and fistula repair.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading